JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Scope & Guideline

Transforming Understanding in Cell Biology

Introduction

Welcome to your portal for understanding JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1079-9893
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1980 to 1981, from 1983 to 2024
AbbreviationJ RECEPT SIG TRANSD / J. Recept. Signal Transduct.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION is dedicated to advancing the understanding of receptor biology and signaling pathways that underpin various physiological and pathological processes. The journal serves as a platform for researchers to disseminate their findings on the roles of receptors in health and disease, particularly focusing on novel therapeutic strategies and drug discovery.
  1. Receptor Pharmacology and Signaling Mechanisms:
    This area encompasses studies exploring the pharmacological properties of various receptors, including GPCRs and ion channels, and their downstream signaling pathways. The aim is to elucidate the molecular mechanisms involved in receptor activation and modulation.
  2. In Silico and Computational Approaches:
    The journal features research utilizing molecular docking, dynamics simulations, and QSAR modeling to predict interactions between receptors and potential therapeutic compounds, underscoring the importance of computational methods in drug discovery.
  3. Therapeutic Applications and Drug Discovery:
    Research focusing on the identification of novel receptor agonists and antagonists, particularly in the context of diseases such as cancer, diabetes, and neurodegenerative disorders, highlighting innovative therapeutic strategies.
  4. Pathophysiological Roles of Receptors:
    Investigations into the roles of receptors in various diseases, including cancer, cardiovascular disorders, and metabolic syndromes, emphasizing the clinical relevance of receptor biology.
  5. Cross-talk Between Signaling Pathways:
    Studies that explore interactions between different signaling pathways mediated by receptors, which can provide insights into complex regulatory mechanisms in cellular responses.
The JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION is witnessing a dynamic evolution in its thematic focus, as evidenced by the recent papers published. This section outlines the emerging trends and themes that are gaining traction within the journal, reflecting current research priorities and scientific advancements.
  1. Targeted Therapy and Precision Medicine:
    An increasing number of studies are focusing on targeted therapies that exploit specific receptor pathways for precision treatment in diseases like cancer, highlighting the shift towards personalized medicine.
  2. Role of Non-Coding RNAs in Receptor Signaling:
    Research on microRNAs and long non-coding RNAs that modulate receptor signaling pathways is gaining prominence, indicating a growing interest in the regulatory roles of these molecules in health and disease.
  3. In Vitro and In Vivo Models for Drug Testing:
    There is a notable trend towards utilizing advanced in vitro and in vivo models to study receptor functions and therapeutic interventions, enhancing the translational aspect of receptor research.
  4. Integrative Approaches Combining Multiple Modalities:
    Emerging studies are increasingly adopting integrative methodologies that combine computational, biochemical, and cellular techniques to provide comprehensive insights into receptor signaling and pharmacology.
  5. Impact of Environmental Factors on Receptor Function:
    Research exploring how environmental changes, such as hypoxia or oxidative stress, influence receptor activities and signaling pathways is becoming more prevalent, reflecting a broader understanding of receptor biology in physiological contexts.

Declining or Waning

While the JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION has consistently focused on key areas of receptor biology, certain themes appear to be diminishing in prominence within the recent publications. This section highlights those topics that have seen a reduced frequency or focus in the journal's output.
  1. Traditional Pharmacology of Known Receptors:
    Research that solely focuses on well-characterized receptors without exploring novel therapeutic implications or innovative methodologies is less frequently published. This shift indicates a move towards more complex and novel studies involving receptor interactions and signaling.
  2. Basic Mechanistic Studies without Clinical Relevance:
    There has been a noticeable decline in purely mechanistic studies that do not connect to clinical applications or therapeutic potential, reflecting a growing expectation for research to have direct implications for treatment or drug development.
  3. Exploration of Less Studied Receptors:
    Research on lesser-known or orphan receptors appears to be waning, as the journal increasingly prioritizes studies that focus on prominent receptors with established clinical relevance, potentially due to the demand for impactful findings.

Similar Journals

MOLECULAR AND CELLULAR BIOCHEMISTRY

Pioneering Insights in Biochemistry and Medicine
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Leading the Charge in Biochemical and Cellular Discoveries
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 1357-2725Frequency: 12 issues/year

The International Journal of Biochemistry & Cell Biology, published by Pergamon-Elsevier Science Ltd, stands as a pivotal resource in the fields of biochemistry and cell biology. With an ISSN of 1357-2725 and an E-ISSN of 1878-5875, this prestigious journal has been a key platform for disseminating cutting-edge research since its inception in 1995. The journal currently holds an impressive Q1 ranking in Biochemistry and a Q2 ranking in Cell Biology for the year 2023, reflecting its commitment to high-quality research and its influence within the scientific community. With a significant Scopus ranking of 94/438 in Biochemistry and 96/285 in Cell Biology, the journal plays a crucial role in advancing knowledge and fostering innovative approaches in these dynamic fields. Though it is not an open-access journal, the International Journal of Biochemistry & Cell Biology remains accessible to a wide audience, making it a vital resource for researchers, professionals, and students alike, who are eager to explore and contribute to the ongoing advancements in biochemistry and cell biology.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Connecting researchers through groundbreaking discoveries.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

Current Molecular Pharmacology

Exploring Innovations in Drug Discovery
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1874-4672Frequency: 7 issues/year

Current Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.

Journal of Biochemistry

Pioneering research in biochemistry and beyond.
Publisher: OXFORD UNIV PRESSISSN: 0021-924XFrequency: 12 issues/year

Journal of Biochemistry, published by Oxford University Press, is a prestigious academic journal that has been at the forefront of biochemical research since its inception in 1922. With an ISSN of 0021-924X and an E-ISSN of 1756-2651, this journal serves as a platform for disseminating high-quality research in the fields of biochemistry, molecular biology, and medicine, holding impressive rankings such as Q2 in Biochemistry and Medicine (miscellaneous) in 2023. As of 2024, the journal continues to explore significant topics in these areas, offering valuable insights for researchers, professionals, and students alike. The journal does not currently offer open access, but it remains a vital resource for anyone in the biochemical community seeking to stay updated on the latest discoveries and advancements. With its rich history and dedication to scientific excellence, the Journal of Biochemistry is an indispensable part of the scholarly landscape.

JOURNAL OF CELLULAR BIOCHEMISTRY

Advancing the Frontiers of Biochemical Research
Publisher: WILEYISSN: 0730-2312Frequency: 12 issues/year

Journal of Cellular Biochemistry is a premier academic journal dedicated to advancing the field of biochemistry and cellular biology. Published by Wiley, this influential journal has a significant impact factor that underscores its relevance and authority within the scientific community. With its ISSN 0730-2312 and E-ISSN 1097-4644, the journal has been on the frontier of research since its inception in 1982, and is expected to continue publishing cutting-edge studies through 2024. As evidenced by its ranking in the 2023 Scopus Quartiles, it holds a rank of Q2 in Biochemistry and Q3 in both Cell and Molecular Biology, placing it among the top tiers of scientific journals in these disciplines. The Journal of Cellular Biochemistry serves as a vital resource for researchers, professionals, and students alike, providing a platform for the dissemination of innovative ideas and findings that shape our understanding of cellular processes and biochemical pathways. Though it does not currently offer Open Access options, its robust peer-review process ensures that each publication meets the highest academic standards, thus solidifying its esteemed position in the landscape of biochemical research.

International Journal of Biological Sciences

Empowering the Global Community with Life Science Insights
Publisher: IVYSPRING INT PUBLISSN: 1449-2288Frequency: 10 issues/year

International Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.

BIOCHEMICAL JOURNAL

Illuminating the Path of Molecular Discovery
Publisher: PORTLAND PRESS LTDISSN: 0264-6021Frequency: 24 issues/year

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Advancing the Frontiers of Cellular and Molecular Science
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

Purinergic Signalling

Charting New Territories in Purinergic Signaling
Publisher: SPRINGERISSN: 1573-9538Frequency: 4 issues/year

Purinergic Signalling, published by Springer, is a pivotal academic journal dedicated to the exploration of purinergic signaling pathways and their implications in various biological processes. Since its inception in 2004, the journal has made significant contributions to the fields of Cell Biology, Cellular and Molecular Neuroscience, and Molecular Biology, consistently ranking in the Q3 category in recent assessments. With a strong focus on the molecular mechanisms of purines and their roles in physiology and pathology, Purinergic Signalling serves as an essential resource for researchers and professionals seeking to understand the complexity of cellular communication. Although it does not offer open access, the journal ensures a broad dissemination of high-quality research findings, making it a vital tool for academic advancement in the fields of neuroscience and molecular biology. Its commitment to scholarly excellence is reflected in its Scopus rankings, where it is competitively positioned within its categories. As we approach its 20th anniversary in 2024, Purinergic Signalling continues to inspire and inform cutting-edge research in the dynamic landscape of life sciences.